共 63 条
Conformational transition of amyloid β-peptide
被引:229
作者:
Xu, YC
Shen, JJ
Luo, XM
Zhu, WL
Chen, KX
Ma, JP
Jiang, HL
机构:
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, State Key Lab Drug Res,Ctr Drug Discovery & Desig, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Shanghai 201203, Peoples R China
[3] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China
[4] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[5] Rice Univ, Dept Bioengn, Houston, TX 77005 USA
来源:
关键词:
molecular dynamics simulation;
D O I:
10.1073/pnas.0501218102
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
The amyloid beta-peptides (A beta s), containing 39-43 residues, are the key protein components of amyloid deposits in Alzheimer's disease. To structurally characterize the dynamic behavior of A beta(40), 12 independent long-time molecular dynamics (MD) simulations for a total of 850 ns were performed on both the wide-type peptide and its mutant in both aqueous solution and a biomembrane environment. In aqueous solution, an a-helix to P-sheet conformational transition for A beta(40) was observed, and an entire unfolding process from helix to coil was traced by MD simulation. Structures with P-sheet components were observed as intermediates in the unfolding pathway of A beta(40). Four glycines (G(25), G(29), G(33), and G(37)) are important for A beta(40) to form beta-sheet in aqueous solution; mutations of these glycines to alanines almost abolished the beta-sheet formation and increased the content of the helix component. In the dipalmitoyl phosphatidylcholine (DPPC) bilayer, the major secondary structure of A beta(40) is a helix; however, the peptide tends to exit the membrane environment and lie down on the surface of the bilayer. The dynamic feature revealed by our MD simulations rationalized several experimental observations for A beta(40) aggregation and amyloid fibril formation. The results of MD simulations are beneficial to understanding the mechanism of amyloid formation and designing the compounds for inhibiting the aggregation of A beta and amyloid fibril formation.
引用
收藏
页码:5403 / 5407
页数:5
相关论文